Qamar Huma 4
4 · Ocugen, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Qamar Huma
Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2025-01-02+1,145,468→ 1,145,468 totalExercise: $0.90Exp: 2035-01-02→ Common Stock (1,145,468 underlying)
Footnotes (1)
- [F1]The option vests annually in equal installments over three years commencing on January 2, 2026, subject to continued service with the Issuer on the applicable vesting dates.